Alternative Blog Styles



Meet Dr. Steve Rose

Dr. Steve RoseSteve is highly respected for his expertise and tireless commitment to finding treatments and cures for vision-robbing retinal diseases.

Dr. Steve Rose 

Newsletter Sign Up

*  
*  
*  
*  


   Please leave this field empty

Posts Tagged ‘stargardt disease’

Research at the monitorDefinitive diagnoses for inherited retinal diseases don’t always come easy, even for the patients of the most knowledgeable doctors. Comments posted to this blog over the past year are a testament to that fact. Many readers are understandably frustrated by a doctor’s inability to determine exactly what retinal condition is affecting them or loved ones.
Read more

NanoparticlesAfter a rigorous review process, the Foundation is funding eight new research projects for a wide range of conditions, including Leber congenital amaurosis (LCA), age-related macular degeneration (AMD) and retinitis pigmentosa (RP). You can read about these exciting projects in an article recently posted on the Foundation’s homepage.

Read more

Lab BeakersWe, at Eye on the Cure, like to keep folks up-to-date on the latest retinal research developments, as soon as they’re vetted – meaning verified as legitimate – and/or come in. But we also appreciate when the mainstream media chimes in, especially when they cite the Foundation’s efforts and expertise.

Read more

In the lab with beakerIt seems there is no dearth of fantastic cures being touted on the Internet and in email inboxes these days. Sort of reminds me of those old Western movies where the itinerant peddler sells the magic elixir that will cure any and all ailments you have. Read more

Rod cells derived from iPSC at the RIKEN labs.I just learned some promising news from the stem cell research front. RIKEN, an innovative research group in Japan, is hoping to launch a clinical trial of an age-related macular degeneration (AMD) treatment derived from induced pluripotent stem cells (iPSC). Based on my current knowledge, this would be the first-ever iPSC-based treatment for the retina to move into a human study.
Read more